ESTRO 2025 - Abstract Book

S1520

Clinical – Mixed sites & palliation

ESTRO 2025

Conclusion: Palliative RT for bone metastases can be delivered efficiently using oART on standard equipment for RT. Omitting the need for a dedicated planning CT reduces the time that patients have to reside in the hospital for palliative RT. This study shows that the availability of oART can be democratized through innovative thinking and optimization of existing procedures, and not only through the purchase of highly specialized and dedicated equipment.

Keywords: Online adaptive, Patient experience, bone mets

2460

Digital Poster Feasibility and acceptability of using electronic patient-reported outcome measures (ePROMs) in follow-up care after radiotherapy Thitikorn Nuamek 1 , Peggy Adwoa Nuamah Kwateng 1,2 , Danya Abdulwahid 1 , Claire Barker 1 , Kathryn Banfill 1 , Neil Bayman 1 , Sarah Bowen-Jones 1 , Clara Chan 1 , Gerard Gurumurthy 1,2 , Margaret Harris 1 , Ashley Horne 1 , Jennifer King 1 , Laura Pemberton 1 , Hamid Younus Sheikh 1 , David Thomson 1 , David Woolf 1 , Janelle Yorke 3,4,5 , James Price 1,2 , Corinne Faivre-Finn 1,2 1 Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom. 2 Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom. 3 Christie Paitent-Centred Research, The Christie NHS Foundation Trust, Manchester, United Kingdom. 4 Division of Nursing, Midwifery, and Social Work, The University of Manchester, Manchester, United Kingdom. 5 School of Nursing, The Hong Kong Polytechnic University, Hong Kong, Hong Kong Purpose/Objective: There is a gap in patient monitoring between the end of radiotherapy and the first follow-up appointment, during which patients may experience severe side effects. Electronic patient-reported outcome measures (ePROMs) enable clinicians to better understand patients’ symptoms and identify those needing intervention. This study aimed to evaluate the feasibility and acceptability of using ePROMs to monitor and support patients after radiotherapy. Material/Methods: Patients with lung and head and neck (HN) cancer treated with curative-intent (chemo)radiotherapy were recruited. ePROM questionnaires were sent to patients at eight timepoints: pre-radiotherapy, mid-radiotherapy, end of radiotherapy, weekly for four weeks post-radiotherapy, and at the first face-to-face follow-up appointment. The